ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based Upon Early, Interim Radiographic Assessment in Advanced Melanoma (The ADAPT-IT Study).

Michael A Postow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.